Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Marksans Pharma Ltd (MARK)

NSE
Currency in INR
Disclaimer
172.00
+4.85(+2.90%)
Closed

MARK Comments

marksans 160 pe fir se aayega
Earnings Quality for fin yr 2022-23 is low. Accruals are about 29%. Rest financials are ok.
Is not giving better yield either improvement in share price or dividend for the last 3 to 5 years.
Is not giving better yield either improvement in share price or dividend for the last 3 to 5 years.
TP 68 upto June 2022
TP 68 upto June 2022
hold after Q2 results will touch 98 plus .......best buy at current price ..good luck anil shetty yelinje
Wait for some time Traget is 200I had purchased 2572 share at rate of 72.50
u have sold or u put on hold?
u have sold or u put on hold?
markson ph is fundamental stong stock hold tgt 150
will cross 100 this month
Any update now about this share
any chance to go up?
Good fundamentals and financials. Strong Management
let it cross 75 then go upside .
very good pharma stock
marksans pharma is 100 percent Roy.It has received USFDA,UKMHRA,TGA
buy it now
Very good company, high potential to grow
Stock prices might fall. Assumption made by studying companies fortune plans and databases
Marksans share target@65 it has got ukmhra and Australian GMP approvals
good stock buy it and hold one year ...and target is INR 200 to 250 to 350 ...
On what basis u say this
Can anyone suggest why d stock price of dis company has'nt done too since past few years?
 because i was holing it since 2016 and waiting for pharma sector to revive now due to covid demand for pharma companies has been on a rise so now it will go to maximum 70-75
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.